The European Commission (EC) has approved the provisional use of Pfizer and BioNTech vaccine for COVID19. The authorization to Pfizer vaccine by the EU has opened the doors for a vaccination program across the European Union (EU). The officials from Pfizer and BioNTech have said that they will soon start delivering the doses of the vaccine. The European Commission (EC) has signed a deal in November with the companies to secure 200 million doses of the vaccine in 2020 and next year. The deal comes with an option to get extra 100 million doses as well. The green signal to the vaccine has come after the European Medicines Agency (EMA) has given a nod to grant provisional marketing authorization to Pfizer vaccine. The officials have said that the vaccine will be used among people who are 16 years and above.
The EMA has said that the first marketing authorization of the COVID19 vaccine in the EU is based on the agency’s scientific opinion, after examining the safety and efficacy of the vaccine. The approval of the Pfizer vaccine in the EU has come two weeks after the American and German-made vaccine has been approved in the US for emergency use authorization. The officials have said that Europe is going to initiate the first phase of vaccination as soon as possible, most probably within a week. Many EU countries such as Italy, France, Austria, and Germany might start the vaccination on 27 December.
Pfizer has been approved by the UK for the first time. The UK has started its historic vaccine rollout early this month. The vaccine has been proven to be 95 percent effective in preventing COVID19 infection in the final stage of the clinical trial. Experts have said that vaccine authorization across the world has been increasing as many European nations have tightened their restrictions due to the second wave of virus infection. The COVID19 pandemic has claimed the lives of around half a million people in Europe since it has emerged. Governments around the world are going through a hard time while preventing the further spread of the virus and keeping the economies afloat.